CN103031367A - VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip - Google Patents
VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip Download PDFInfo
- Publication number
- CN103031367A CN103031367A CN2011103008815A CN201110300881A CN103031367A CN 103031367 A CN103031367 A CN 103031367A CN 2011103008815 A CN2011103008815 A CN 2011103008815A CN 201110300881 A CN201110300881 A CN 201110300881A CN 103031367 A CN103031367 A CN 103031367A
- Authority
- CN
- China
- Prior art keywords
- seq
- sequence
- site
- tag
- phase chip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a VHL (Von Hippel Lindau) genetic mutation detection specific primer and a liquid phase chip. The liquid phase chip mainly comprises ASPE (Allele Specific Primer Extension) primers, microspheres coated by an anti-tag sequence, and amplimers, wherein the ASPE primers consist of tag sequences at a 5' end and specific primer sequences specific to target genetic mutation sites at a 3' end; and the specific primer sequences are: SEQ ID NO.13 and SEQ ID NO.14 specific to a T240A site; SEQ ID NO.15 and SEQ ID NO.16 specific to a T254C site; SEQ ID NO.17 and SEQ ID NO.18 specific to a T266A site; SEQ ID NO.19 and SEQ ID NO.20 specific to a T286T site; SEQ ID NO.21 and SEQ ID NO.22 specific to a G388C site; and/or SEQ ID NO.23 and SEQ ID NO.24 specific to a 444delT site. The matching rate between a detection result of the liquid phase chip provided by the invention and a sequencing method is up to 100 percent, and wild and mutant parallel detection of a plurality of mutant sites is realized.
Description
Technical field
The invention belongs to biology field, relate to medical science and biotechnology, concrete a kind of vhl gene mutation detection specific primer and the liquid-phase chip of relating to.
Background technology
Vhl gene is gained the name in Von Hippel-Lindau (VHL) disease, contains 14543bp, comprises 3 exons and 2 introns.The VHL disease is clinical very rare familial autosomal dominant neoplastic disease, comprise central nervous system hemangioblastoma, internal tumor and tumour etc., 1993, Latif etc. were positioned vhl gene for chromosome 3p 25-26 by linkage analysis, and had successfully cloned vhl gene first.Vhl gene is cancer suppressor gene, and the inactivation of this gene can cause normal VHL protein synthesising disorder, with the genesis of clear cell carcinoma of kidney (clear cell renal cell carcinoma, CCRCC) close relationship is arranged.Make important progress for the structure of vhl gene and the research of function and regulatory pathway thereof at present, and the inactivation of clear and definite vhl gene mechanism, mainly comprise transgenation, loss of heterozygosity and methylating.The present invention mainly detects vhl gene common six kinds of genotype T240A, T254C, T266A, C286T, G388C and 444delT.
At present, the method that determination and analysis is carried out in vhl gene sudden change seldom mainly contains direct sequencing and PCR-RFLP analytical method, and wherein the most frequently used method has the PCR-RFLP analytical method.The PCR-RFLP method is based on the change of the restriction enzyme enzyme recognition site that transgenation causes, as losing or produce novel site in the site, by a certain specific fragment of pcr amplification, use again the digestion with restriction enzyme amplified production, the size of electrophoresis observation fragment, this method can directly be judged genotype for detection of the transgenation that restriction enzyme site changes, but this method can not be used for not producing the detection in Gene Mutation of new restriction enzyme site.Again, more than these methods all exist the limitation that detects flux, can only detect a kind of mutation type at every turn, can not satisfy the needs of practical application.
Summary of the invention
One of purpose of the present invention provides the vhl gene sudden change and detects liquid-phase chip, and this liquid-phase chip can be used for separately or parallel detection vhl gene six kinds of common genotypic T240A, T254C, T266A, C286T, G388C and 444delT wild-type and mutants.
The technical scheme that realizes above-mentioned purpose is as follows:
A kind of vhl gene sudden change detects liquid-phase chip, includes:
(A). the wild-type that designs respectively for the different mutational sites of vhl gene and the ASPE primer of mutant: every kind of ASPE primer is comprised of the tag sequence of 5 ' end and 3 ' the end specific primer sequence for the goal gene mutational site, and described specific primer sequence is: for SEQ ID NO.13 and the SEQ ID NO.14 in T240A site; SEQ ID NO.15 and SEQ ID NO.16 for the T254C site; SEQ ID NO.17 and SEQ ID NO.18 for the T266A site; SEQID NO.19 and SEQ ID NO.20 for the C286T site; SEQ ID NO.21 and SEQ ID NO.22 for the G388C site; And/or for SEQ ID NO.23 and the SEQ ID NO.24 in 444delT site; Described tag sequence is selected from SEQ ID NO.1～SEQ IDNO.12;
(B). anti-tag sequence microballoon coated, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from SEQ ID NO.25～SEQ ID NO.36, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). be used for amplifying the primer that needs target sequence detection, that have corresponding mutational site.
Preferably, described amplimer is SEQ ID NO.37 and the SEQID NO.38 for T240A, T254C, T266A, C286T site; And/or for SEQ ID NO.39 and the SEQ ID NO.40 in G388C, 444delT site.
Preferably, described ASPE primer is for the sequence that is comprised of SEQ ID NO.1 and SEQ ID NO.13 in T240A site and the sequence that is comprised of SEQ ID NO.2 and SEQ ID NO.14; For the sequence that is formed by SEQ ID NO.3 and SEQ IDNO.15 in T254C site and the sequence that is formed by SEQ ID NO.4 and SEQ ID NO.16; For the sequence that is formed by SEQID NO.5 and SEQ ID NO.17 in T266A site and the sequence that is formed by SEQ ID NO.6 and SEQ ID NO.18; For the sequence that is formed by SEQ ID NO.7 and SEQ ID NO.19 in C286T site and the sequence that is formed by SEQ ID NO.8 and SEQ IDNO.20; For the sequence that is formed by SEQ ID NO.9 and SEQ ID NO.21 in G388C site and the sequence that is formed by SEQID NO.10 and SEQ ID NO.22; And/or for the sequence that is formed by SEQ ID NO.11 and SEQ IDNO.23 in 444delT site and the sequence that is formed by SEQ ID NO.12 and SEQ ID NO.24.
Another object of the present invention provides the Auele Specific Primer that detects for the vhl gene sudden change.
The technical scheme that realizes above-mentioned purpose is as follows:
Be used for the Auele Specific Primer that the vhl gene sudden change detects, it is: for SEQ ID NO.13 and the SEQID NO.14 in T240A site; SEQ ID NO.15 and SEQ ID NO.16 for the T254C site; SEQ ID NO.17 and SEQ ID NO.18 for the T266A site; SEQ ID NO.19 and SEQ ID NO.20 for the C286T site; SEQID NO.21 and SEQ ID NO.22 for the G388C site; And/or for SEQ ID NO.23 and the SEQ ID NO.24 in 444delT site.
Major advantage of the present invention is:
1. the identical rate of detection method provided by the present invention and sequencing is up to 100%.And detect the needed time well below sequencing technologies commonly used, realistic especially application needs.Prepared vhl gene sudden change detects liquid-phase chip and has extraordinary signal-noise ratio, and basically there is not cross reaction between designed probe and the anti-tag sequence, choosing and tag sequence label and the specifically combination of ASPE primer of tag sequence label, anti-tag sequence label, can avoid cross reaction, realize the parallel detection in a plurality of mutational sites.
2. the present invention has chosen optimum combination by the design experiences of contriver's long-term accumulation and a large amount of experimental implementation from numerous Auele Specific Primers.The ASPE primer specificity primer of the present invention's design can sensitive be identified the mutational site of target detect specifically, accurately distinguishes the genotype of various types; In same reaction system, between the different Auele Specific Primers, basically do not have cross reaction between the pcr amplification product of Auele Specific Primer and non-target detect, detection specificity is good, and cross reacting rate is lower than 3%; Except detecting Single locus sudden change situation, the also sudden change situation in a plurality of mutational sites of simultaneously parallel detection, it is consistent to detect effect.
3. detection method step of the present invention is simple, 6 kinds of mutational sites are detected and can be finished 2 amplifications that contain the target sequence in mutational site by a step PCR, many uncertain factors of existing in the complex operations processes such as repeated multiple times PCR have been avoided, thereby can greatly improve Detection accuracy, embodied accurate while qualitative and quantitative analysis feature.
4. not only to have overcome traditional solid phase chip susceptibility not high in the present invention, and the defective that the repeatability of detected result is poor is improved existing liquid-phase chip technology simultaneously, so that prepared microballoon can be applicable to different test items, has very strong expansion.The fluorescent signal value that detects improves greatly, thereby so that the sensitivity that detects is further enhanced, signal to noise ratio strengthens, and detected result more accurately and reliably.
Embodiment
Embodiment 1VHL gene mutation detection liquid-phase chip mainly includes:
One, ASPE primer
Wild-type and mutant for vhl gene six kinds of common genotype T240A, T254C, T266A, C286T, G388C and 444delT design respectively specific primer sequence.The ASPE primer is comprised of " tag sequence+specific primer sequence ".The ASPE primer sequence is as shown in the table:
The ASPE primer sequence (tag sequence+specific primer sequence) of table 1VHL gene
Every the ASPE primer comprises two parts, and 5 ' end is the specificity tag sequence for anti-tag sequence on the corresponding microballoon, and 3 ' end is mutant or the special primer fragment (as shown in Table 1 above) of wild-type.All ASPE primers are synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with respectively the stock solution of 100pmol/mL with 10mmol/L Tris Buffer.
Two, the coated microballoon of anti-tag sequence
According to designed ASPE Auele Specific Primer fragment, select the tag sequence, reduce to greatest extent between the anti-tag sequence of each microballoon and secondary structure that tag and ASPE Auele Specific Primer fragment may form, corresponding anti-tag sequence is as shown in table 2 on 12 kinds of microballoons numberings of selection and the microballoon:
Corresponding anti-tag sequence on table 2 microballoon numbering and the microballoon
12 kinds of microballoons selecting are coated in the anti-tag sequence on the microballoon available from U.S. Luminex company.Be connected with the spacerarm sequence of 5-10 T between anti-tag sequence and the microballoon, namely add the spacerarm sequence of the preceding paragraph 5-10 T before each anti-tag sequence, the anti-tag sequence is synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.With synthetic anti-tag sequence sterilization ddH
2O is made into the stock solution of 100nmol/ml.Described spacerarm is for being used for anti-tag and microsphere surface is spaced apart or anti-tag is placed the sequence of hydrophilic environments.By the spacerarm sequence of suitable length is set between anti-tag sequence and microballoon, can reduce sterically hinderedly, improve the efficient of hybridization and the specificity of hybridization.Common spacerarm sequence comprises poly dT, i.e. poly (dT), and oligomerization four polyoxyethylene glycol and (CH2) n spacerarm (n 〉=3) are such as (CH2) 12, (CH2) 18 etc.In addition, if exist poly (dA) to disturb, can also use poly (TTG) as spacerarm.Spacerarm of the present invention is preferably 5-10 T, and the process that microballoon is coated with is as follows:
Get respectively 5 * 10
6The carboxylated microballoon of individual above-mentioned numbering (available from Luminex company) is suspended in the MES solution of 50ul 0.1mol/L (pH4.5), adds the synthetic anti-tag molecule (100nmol/ml) of 10ul.EDC (N-(3-Dimethylaminopropyl-N-ethylcarbodiimide) (available from the Pierce Chemical company) working fluid of preparation 10ng/ml.The EDC working fluid that adds 2.5ul in the microballoon suspension, constant-temperature incubation 30 minutes adds the EDC working fluid of 2.5ul again, and constant-temperature incubation is 30 minutes again.After reaction finished, the Tween-20 washing with 0.02% was once washed once with 0.1% SDS liquid again.The microballoon that is coated with the anti-tag sequence after the washing is resuspended in the Tris-EDTA solution [10mmol/L Tris (pH8.0)] of 100ul, and among the 1mmol/L EDTA, 2-8 ℃ keeps in Dark Place.
Three, amplify the primer of the target sequence that contains the mutational site
For vhl gene six kinds of common genotype T240A, T254C, T266A, C286T, G388C and 444delT, design of amplification primers amplifies 2 target sequences that contain 6 mutational sites to (seeing Table 3).
Table 3 amplifies the primer of the target sequence with mutational site
All primers are synthetic by Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.Every primer after synthetic is mixed with respectively the stock solution of 100pmol/mL with 10mmol/LTrisBuffer.
Embodiment 2 uses embodiment 1 described vhl gene sudden change to detect liquid-phase chip to the detection of sample
The prescription of described various solution is as follows:
MES damping fluid (pH5.0) prescription (250ml) of 50mM:
2 * Tm hybridization buffer
| Reagent | The source | Final concentration | The consumption of every 250ml |
| 1MTris-HCl，pH8.0 | SigmaT3038 | 0.2M | 50ml |
| 5MNaCl | Sigma S5150 | 0.4M | 20ml |
| Triton X-100 | Sigma T8787 | 0.16％ | 0.4ml |
Be stored in 4 ℃ after the filtration.
The ExoSAP-IT test kit is available from U.S. USB company.
Biotin labeled dCTP is available from Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.
One, the DNA extraction of sample:
With reference to " molecular cloning " methods involving about DNA extraction, obtain DNA to be detected.
Two, the pcr amplification of testing sample
Design 2 pairs of primers, one step of multiplex PCR amplifies 2 target sequences that contain respectively vhl gene six kinds of common genotype T240A, T254C, T266A, C286T, G388C and 444delT, wherein, T240A, T254C, T266A and C286T are positioned at same amplified production, and G388C and 444delT are positioned at same amplified production.The product size is respectively 367bp and 456bp, and primer sequence (SEQ ID NO.37-40) is seen shown in the above-mentioned table 3.
At first prepare the multiple PCR primer working fluid: respectively get respectively the primer stock solution 100ul of SEQ ID NO.37-40 in the 1.5ml Eppendorf tube, mix and be the multiple PCR primer working fluid.The multi-PRC reaction system is as follows:
2 * damping fluid (contains Mg
2+) 25ul
DNTP (each 2.5mmol/L) 4ul
Taq enzyme (5U/ul) 0.2ul
Multiple PCR primer working fluid (each 8.3pmol/mL) 6ul
Template DNA (10ng/ul) 2ul
ddH
2O 12.8ul
Be total to 50ul
The pcr amplification program is: 95 ℃ of 3min; 94 ℃ of 30s, 56 ℃ of 30s, 72 ℃ of 40s, 30 circulations; 72 ℃ of 10min; 4 ℃ save backup.
Three, the enzyme of PCR product is cut processing
1. get the reacted product of 7.5ul PCR, add 1ul 10 * SAP damping fluid, 1ul SAP enzyme and 0.5ul Exo-I enzyme;
2.37 ℃ hatch 15min, hatch 15min for 80 ℃, the enzyme that deactivation is unnecessary.The product that enzyme is cut after the processing is directly used in follow-up ASPE primer extension reaction.
Four, site-specific primer extension reaction (ASPE)
Utilize the ASPE primer of above-mentioned design to carry out primer extension reaction, in reaction process, mix biotin labeled dCTP, thereby make a plurality of biotin labeling on the reacted product band.
At first prepare the ASPE primer working fluid that mixes: get respectively the corresponding wild-type of gene to be detected and mutant ASPE primer stock solution 10ul in the 1.5ml Eppendorf tube, add 10mmol/L Tris Buffer and mend to 200ul, mix and be ASPE mix primer working fluid.The system of ASPE reaction is as follows:
10 * damping fluid 2ul
MgCl
2(50mmol/L) 0.5ul
Biotin-dCTP(400umol/L) 0.25ul
DATP, dGTP, dTTP mixed solution (each 100umol/L) 1ul
Tsp enzyme (5U/ul) 0.25ul
ASPE primer working fluid (each 500nmol/L) 1ul that mixes
Enzyme is cut the pcr amplification product 5ul of processing
ddH
2O 10ul
Be total to 20ul
Response procedures is: 96 ℃ of 2min; 94 ℃ of 30s, 54 ℃ of 1min, 72 ℃ of 2min, 30 circulations; 4 ℃ save backup.
Five, hybridization
According to the design the ASPE primer, the corresponding 12 kinds of coated microballoons of every group selection (as described in Example 1), every kind of microballoon concentration is 2.5 * 10
5Individual/ml;
2. get respectively the microballoon of every kind of numbering of 1ul in the Eppendorf tube of 1.5ml;
3. microballoon is in 〉=centrifugal the 1-2min of 10000g;
4. supernatant discarded, microballoon is resuspended in 2 * Tm hybridization buffer of 100ul, the vortex mixing;
5. get the above-mentioned microballoon suspension of 25ul in the corresponding hole of 96 hole filter plates, control wells adds the ddH of 25ul
2O;
6. get the ASPE reaction solution of 5-25ul in corresponding hole, use ddH
2O complements to 50ul;
7. encase 96 orifice plates with lucifuge with masking foil, 95 ℃ of 60s, 37 ℃ of 15min are hatched hybridization;
8. the microballoon after the hybridization is in 〉=centrifugal the 2-5min of 3000g;
9. remove supernatant, microballoon is resuspended in 1 * Tm hybridization buffer of 75ul;
10. microballoon is in 〉=centrifugal the 2-5min of 3000g;
11. microballoon is resuspended in 1 * Tm hybridization buffer of 75ul, adding 15ul concentration is the SA-PE (SA-PE) of 10ug/ml;
12.37 ℃ hatch 15min, on the Luminex instrument, detect.
Six, the result detects and data analysis
The reaction after product detects by Luminex serial analysis instrument.Greater than 100 as the cut-off value, the MFI value that detects when mutant is judged that there is this mutation type in this sample, otherwise is judged that this sample is corresponding wild-type greater than 100 the time take mutant fluorescent value (MFI).
Use present method to detect the vhl gene sudden change of great amount of samples, compare with the liquid-phase chip result with the sequencing detection, calculate the identical rate of method detected result provided by the present invention.Present method detects 20 increments vhl gene type detected result and the sequencing result rate of coincideing originally and reaches 100%.As seen vhl gene sudden change provided by the present invention detects the mutation type that liquid-phase chip can detect vhl gene exactly, and the result is reliable and stable.
One of table 4 pattern detection result (MFI)
Table 5 pattern detection result's (MFI) two
Table 6 sample vhl gene mutation type analytical results
| Catalogue number(Cat.No.) | The liquid-phase chip detected result | Sequencing result |
| 1 | Wild-type | Wild-type |
| 2 | Wild-type | Wild-type |
| 3 | The T240A sudden change | The T240A sudden change |
| 4 | Wild-type | Wild-type |
| 5 | The T266A sudden change | The T266A sudden change |
| 6 | Wild-type | Wild-type |
| 7 | Wild-type | Wild-type |
| 8 | Wild-type | Wild-type |
| 9 | Wild-type | Wild-type |
| 10 | Wild-type | Wild-type |
| 11 | The G388C sudden change | The G388C sudden change |
| 12 | Wild-type | Wild-type |
| 13 | Wild-type | Wild-type |
| 14 | Wild-type | Wild-type |
| 15 | Wild-type | Wild-type |
| 16 | Wild-type | Wild-type |
| 17 | The C286T sudden change | The C286T sudden change |
| 18 | Wild-type | Wild-type |
| 19 | Wild-type | Wild-type |
| 20 | Wild-type | Wild-type |
The liquid-phase chip of the ASPE primer that embodiment 3 is different is to the detection in vhl gene mutational site
One, the design (selection of tag sequence and Anti-tag sequence) of liquid-phase chip preparation
Detect liquid-phase chip as example take vhl gene T240A and T254C site mutation, respectively for the wild-type of T240A and T254C and the specific primer sequence of mutant design ASPE primer 3 ' end, the tag sequence of ASPE primer 5 ' end then is selected from SEQ ID NO.1-SEQ ID NO.12, accordingly, the anti-tag sequence with corresponding tag sequence complementary pairing that is coated on the microballoon is selected from SEQ ID NO.25-SEQ ID NO.36.Specific design is shown in following table (table 7).Synthetic, the coated microballoon of anti-tag sequence of ASPE primer, amplimer, detection method are described like embodiment 1 and embodiment 2.
The design of table 7 liquid-phase chip preparation
Two, sample detection
Adopt the liquid-phase chip of above-mentioned design preparation, by embodiment 2 described testing processes and method sample 21-40 is detected, detected result is as follows:
Table 8 pattern detection result and gene mutation analysis
Table 9 pattern detection result and gene mutation analysis
From experimental result as can be known, the ASPE primer uses different Tag sequences, and its result is still reliable and stable, but the ASPE primer is selected when the tag sequence is arranged in pairs or groups with specific primer sequence among the embodiment 1, effect better (signal to noise ratio is better) is referring to present embodiment test group 1 and test group 5.Other different tag sequences and specific primer sequence collocation, with coming to the same thing of embodiment 2 and present embodiment, concrete data are omitted.
Other is for the liquid-phase chip in different mutational sites, and the ASPE primer uses different Tag sequences, and its result is still reliable and stable, and selects when the tag sequence is with the specific primer sequence collocation among the embodiment 1, and effect is better, concrete data omission.
The selection of embodiment 4VHL detection in Gene Mutation specific primer sequence
One, the design (selection of wild-type and mutant specific primer sequence) of liquid-phase chip preparation
Detect liquid-phase chip as example take the mutational site of vhl gene T266A and G388C, take the forward or backwards complementary sequence of this place, mutational site target sequence as template, respectively for the wild-type of T266A and G388C and the specific primer sequence of mutant design ASPE primer 3 ' end, comprise preferred specific primer sequence and 2 alternative specific primer sequences in the embodiment of the invention 1, as shown in table 10.Wherein,
Interior base is the mutational site.
Table 10 specific primer sequence
Detect liquid-phase chip as example take the mutational site of vhl gene T266A and G388C, select different specific primer sequences for T266A and G388C, the tag sequence of ASPE primer 5 ' end then is fixed as the best effect sequence among the embodiment 1, and select with it corresponding anti-tag sequence, specific design is shown in following table (table 11).Synthetic, the coated microballoon of anti-tag sequence of ASPE primer, amplimer, detection method are described like embodiment 1 and embodiment 2.
Two of the design of table 11 liquid-phase chip preparation
Two, sample detection
Adopt the liquid-phase chip of above-mentioned design preparation, by embodiment 2 described testing processes and method sample 41-60 is detected, detected result is as follows:
Table 12 pattern detection result and gene mutation analysis
Table 13 pattern detection result and gene mutation analysis
By present embodiment as seen, when the ASPE primer was selected among the embodiment 1 collocation of specific primer sequence and tag sequence, effect better (signal to noise ratio is better) was referring to present embodiment test group 7 and test group 10.Other derives from different specific primer sequences and the collocation of tag sequence of the forward or backwards complementary sequence of place, target detect site sequence, with coming to the same thing of embodiment 2 and present embodiment, namely still be that the specific primer sequence described in the embodiment 1 is better from different tag sequence arranging effects, concrete data are omitted.
Other is for multiple specific primer sequence and the collocation of tag sequence in the multiple specific primer sequence in identical mutation site or different mutational site, with coming to the same thing of embodiment 2 and present embodiment, it is embodiment 1 selected Auele Specific Primer, has better signal to noise ratio, it is also better to detect effect, and concrete data are omitted.
More than be for the specifying of possible embodiments of the present invention, but this embodiment limits claim of the present invention, allly do not break away from the equivalence that skill spirit of the present invention does and implement or change, all should be contained in the claim of the present invention.
Claims (6)
1. a vhl gene sudden change detects liquid-phase chip, it is characterized in that, includes:
(A). the wild-type that designs respectively for the different mutational sites of vhl gene and the ASPE primer of mutant: every kind of ASPE primer is comprised of the tag sequence of 5 ' end and 3 ' the end specific primer sequence for the goal gene mutational site, and described specific primer sequence is: for SEQ ID NO.13 and the SEQ ID NO.14 in T240A site; SEQ ID NO.15 and SEQ ID NO.16 for the T254C site; SEQ ID NO.17 and SEQ ID NO.18 for the T266A site; SEQID NO.19 and SEQ ID NO.20 for the C286T site; SEQ ID NO.21 and SEQ ID NO.22 for the G388C site; And/or for SEQ ID NO.23 and the SEQ ID NO.24 in 444delT site; Described tag sequence is selected from SEQ ID NO.1～SEQ IDNO.12;
(B). anti-tag sequence microballoon coated, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from SEQ ID NO.25～SEQ ID NO.36, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C). be used for amplifying the primer that needs target sequence detection, that have corresponding mutational site.
2. vhl gene sudden change according to claim 1 detects liquid-phase chip, it is characterized in that described amplimer is: for SEQ ID NO.37 and the SEQ ID NO.38 in T240A, T254C, T266A, C286T site; And/or for SEQ ID NO.39 and the SEQ ID NO.40 in G388C, 444delT site.
3. vhl gene sudden change according to claim 1 detects liquid-phase chip, it is characterized in that described ASPE primer is: for the sequence that is formed by SEQ ID NO.1 and SEQ ID NO.13 in T240A site and the sequence that is formed by SEQ ID NO.2 and SEQ IDNO.14; For the sequence that is formed by SEQ ID NO.3 and SEQ ID NO.15 in T254C site and the sequence that is formed by SEQID NO.4 and SEQ ID NO.16; For the sequence that is formed by SEQ ID NO.5 and SEQ ID NO.17 in T266A site and the sequence that is formed by SEQ ID NO.6 and SEQ ID NO.18; For the sequence that is formed by SEQ ID NO.7 and SEQ ID NO.19 in C286T site and the sequence that is formed by SEQ ID NO.8 and SEQ ID NO.20; For the sequence that is formed by SEQ ID NO.9 and SEQ ID NO.21 in G388C site and the sequence that is formed by SEQ ID NO.10 and SEQ ID NO.22; And/or for the sequence that is formed by SEQ ID NO.11 and SEQ ID NO.23 in 444delT site and the sequence that is formed by SEQ IDNO.12 and SEQ ID NO.24.
4. vhl gene sudden change according to claim 1 detects liquid-phase chip, it is characterized in that,
(A) described ASPE primer is: for the sequence that is comprised of SEQ ID NO.1 and SEQ ID NO.13 in T240A site and the sequence that is comprised of SEQ ID NO.2 and SEQ ID NO.14; For the sequence that is formed by SEQ ID NO.3 and SEQ IDNO.15 in T254C site and the sequence that is formed by SEQ ID NO.4 and SEQ ID NO.16; For the sequence that is formed by SEQID NO.5 and SEQ ID NO.17 in T266A site and the sequence that is formed by SEQ ID NO.6 and SEQ ID NO.18; For the sequence that is formed by SEQ ID NO.7 and SEQ ID NO.19 in C286T site and the sequence that is formed by SEQ ID NO.8 and SEQ IDNO.20; For the sequence that is formed by SEQ ID NO.9 and SEQ ID NO.21 in G388C site and the sequence that is formed by SEQID NO.10 and SEQ ID NO.22; With for the sequence that is formed by SEQ ID NO.11 and SEQ IDNO.23 in 444delT site and the sequence that is formed by SEQ ID NO.12 and SEQ ID NO.24;
(B) anti-tag sequence microballoon coated, that have the different colours coding is arranged, also be provided with the spacerarm sequence in the middle of described anti-tag sequence is connected with microballoon; Described anti-tag sequence is selected from SEQ ID NO.25～SEQ ID NO.36, and described anti-tag sequence can be correspondingly with (A) in selected tag sequence complementary pairing;
(C) described amplimer is: for SEQ ID NO.37 and the SEQ IDNO.38 in T240A, T254C, T266A, C286T site; With SEQ ID NO.39 and the SEQ ID NO.40 for G388C, 444delT site.
5. each described vhl gene sudden change detects liquid-phase chip according to claim 1-4, it is characterized in that described spacerarm is 5-10 T.
6. be used for the Auele Specific Primer that the vhl gene sudden change detects, it is characterized in that described specific primer sequence is: for SEQ ID NO.13 and the SEQ ID NO.14 in T240A site; SEQ ID NO.15 and SEQ ID NO.16 for the T254C site; SEQ ID NO.17 and SEQ ID NO.18 for the T266A site; SEQ ID NO.19 and SEQ IDNO.20 for the C286T site; SEQ ID NO.21 and SEQ ID NO.22 for the G388C site; And/or for SEQ IDNO.23 and the SEQ ID NO.24 in 444delT site.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110300881.5A CN103031367B (en) | 2011-09-30 | 2011-09-30 | VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110300881.5A CN103031367B (en) | 2011-09-30 | 2011-09-30 | VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103031367A true CN103031367A (en) | 2013-04-10 |
| CN103031367B CN103031367B (en) | 2015-02-04 |
Family
ID=48018766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110300881.5A Active CN103031367B (en) | 2011-09-30 | 2011-09-30 | VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103031367B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105063231A (en) * | 2015-09-15 | 2015-11-18 | 北京大学第一医院 | Method of detecting VHL gene mutation of fetal cells in amniotic fluid and kit |
| CN107385092A (en) * | 2017-09-08 | 2017-11-24 | 银川安龙基因科技有限公司 | A kind of Solid phase PCR kit for detecting vhl gene mutation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101250593A (en) * | 2008-02-03 | 2008-08-27 | 广州益善生物技术有限公司 | Papillomavirus detection and parting method as well as liquid phase chip thereof |
| CN101445831A (en) * | 2008-12-23 | 2009-06-03 | 广州益善生物技术有限公司 | FSHR gene mutation detection liquid phase chip and detection method thereof |
-
2011
- 2011-09-30 CN CN201110300881.5A patent/CN103031367B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101250593A (en) * | 2008-02-03 | 2008-08-27 | 广州益善生物技术有限公司 | Papillomavirus detection and parting method as well as liquid phase chip thereof |
| CN101445831A (en) * | 2008-12-23 | 2009-06-03 | 广州益善生物技术有限公司 | FSHR gene mutation detection liquid phase chip and detection method thereof |
Non-Patent Citations (1)
| Title |
|---|
| SHINGO ASHIDA EC.AL: "Molecular detection of von hippel-lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status", 《THE JOURNAL OF UROLOGY》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105063231A (en) * | 2015-09-15 | 2015-11-18 | 北京大学第一医院 | Method of detecting VHL gene mutation of fetal cells in amniotic fluid and kit |
| CN107385092A (en) * | 2017-09-08 | 2017-11-24 | 银川安龙基因科技有限公司 | A kind of Solid phase PCR kit for detecting vhl gene mutation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103031367B (en) | 2015-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102994619A (en) | NRAS gene mutation detection specificity primer and liquid chip thereof | |
| CN102134605B (en) | Single-nucleotide polymorphism (SNP) detection specific primer of CYP2C19 gene and liquid phase chip | |
| CN102994617A (en) | HRAS gene mutation detection specificity primer and liquid chip thereof | |
| CN102994621B (en) | PTPN11 gene mutation detection specificity primer and liquid chip thereof | |
| CN103374609B (en) | ABO gene mutation detection specific primers and liquid chip | |
| CN103031370B (en) | RB1 gene mutation detection specific primer and liquid chip | |
| CN103031367B (en) | VHL (Von Hippel Lindau) genetic mutation detection specific primer and liquid phase chip | |
| CN103031369B (en) | CDKN2A gene mutation detection specific primer and liquid chip | |
| CN103031365B (en) | ATM gene mutation detection specific primer and liquid chip | |
| CN102912002B (en) | ABCB2 gene polymorphism detection specific primers and liquid chip | |
| CN102304567B (en) | Polymorphic detection specific primers and liquid phase chip in 8 q 24 section of chromosome | |
| CN102010898B (en) | EPHX1 (Microsomal epoxide hydrolase, mEH, EPHX1) gene detection specific primer and liquid phase chip | |
| CN102559850B (en) | ApoA5 genic mutation detection specific primer and liquid phase chip | |
| CN102181573B (en) | Specific primers and liquid-phase chip for detection of KITLG gene | |
| CN102994622B (en) | MET gene mutation detection specificity primer and liquid chip thereof | |
| CN102191336B (en) | MYC gene single nucleotide polymorphism (SNP) detection specific primer and liquid-phase chip | |
| CN102952866B (en) | Specific primer and liquid chip for detecting polymorphism of DPYD (dihydropyrimidine dehydrogenase) gene | |
| CN102994625B (en) | PIK3R1 gene mutation detection specificity primer and liquid chip thereof | |
| CN102994623B (en) | STK11 gene mutation detection specificity primer and liquid chip thereof | |
| CN103031371B (en) | CDH1 gene mutation detection specific primer and liquid chip | |
| CN102952870B (en) | Specific primer and liquid chip for detecting polymorphism of SLC22A2 gene | |
| CN103374608B (en) | MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) gene mutation detection specific primers and liquid chip | |
| CN102952867B (en) | Specific primer and liquid chip for detecting polymorphism of SLC22A6 gene | |
| CN102888444B (en) | Factor II and Factor V genetic polymorphism detection specific primer and liquid-phase chip | |
| CN103031366B (en) | FGFR2 gene mutation detection specific primer and liquid chip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant after: Surexam Biological Technology Co., Ltd. Address before: Five 510663 Guangdong city of Guangzhou province Guangzhou Science City Moon Road No. 80, Guangzhou technology innovation base B, C Applicant before: Guangzhou Yishan Biotechnology Co., Ltd. |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU YISHAN BIOTECHNOLOGY CO., LTD. TO: SUREXAM BIOTECHNOLOGY CO., LTD. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |